Coronavirus 2019-2020 thread (no unsubstantiated rumours!)


KYli

Captain
Please, Log in or Register to view URLs content!


If that were China, it would be called manipulation and lying. And we know it's all about who's the one that's going to make all the money.

NYT has already accused Sinopharm of requesting an approval for an unproven vaccine. Its claim that Sinopharm has not completed the clinical phase 3 trial.

The Oxford vaccine is definitely untrustworthy. Those limited number of people who received half dose are from much younger age group than other trials. Small population plus age difference would suggest data manipulation.
 

supercat

Junior Member
NYT has already accused Sinopharm of requesting an approval for an unproven vaccine. Its claim that Sinopharm has not completed the clinical phase 3 trial.

The Oxford vaccine is definitely untrustworthy. Those limited number of people who received half dose are from much younger age group than other trials. Small population plus age difference would suggest data manipulation.
I think while Pfizer, Mordena, and Oxford vaccines are applying for emergency use, the Sinopharm vaccines (2 of them) have already been approved for emergency use and will apply for regular use next month. It's unmitigated hypocrisy that NYT does not point out the parallel between what the Western pharmaceutical companies are planning to do and what Sinopharm has done.

In other news, it's sad that a lot of Filipino nurses died of COVID-19.
Covid-19 is taking a devastating toll on Filipino American nurses
Nearly a third of the nurses who've died of coronavirus in the US are Filipino, even though Filipino nurses make up just 4% of the nursing population nationwide.
Please, Log in or Register to view URLs content!
 
Last edited:

emblem21

Junior Member
Registered Member
I think while Pfizer, Mordena, and Oxford vaccines are applying for emergency use, the Sinopharm vaccines (2 of them) have already been approved for emergency use and will apply for regular use next month. It's unmitigated hypocrisy that NYT does not point out the parallel between what the Western pharmaceutical companies are planning to do and what Sinopharm has done.

In other news, it's sad that a lot of Filipino nurses died of COVID-19.

Please, Log in or Register to view URLs content!
Imagine what is going to happen then the USA has much less in terms of doctors and nurses to face this crisis, it could end up doing what WW1 and WW2 failed to do, make the USA lose of millions of lives without firing a single gunshot
 

SteelBird

Major
It comes to the question will you take an injection when the vaccines be available? I think the answer depends on where you live and which vaccines are available to you. For me, I will wait at least 3 to 6 months before I decide to take one. As China has promised, vaccines available for us might come from China. Further, we are not in Covid-19 crisis. So, there's no hurry for me.
 

j17wang

Junior Member
Registered Member
Look like Sinopharm would be the first Chinese vaccine to gain regulatory approval. However, it hasn't release the efficacy rate yet.
Please, Log in or Register to view URLs content!

China Covid-19 vaccine maker seeks approval for public use

BEIJING (BLOOMBERG) - A leading Chinese vaccine developer has applied for authorisation to bring its Covid-19 vaccine to the market, seeking to get a jump on Western rivals as the race for a working shot against the pandemic enters the final stretch.

China National Biotec Group Co. has submitted an application to Chinese regulators, reported state media Xinhua Finance on Wednesday (Nov 25), citing parent company Sinopharm's vice general manager Shi Shengyi.

The application likely includes data from the company's Phase III human testing conducted in the Middle East and South America.

Stocks related to Sinopharm Group, including its Hong Kong unit, surged on Wednesday after the news.

A CNBG spokeswoman said she had no further information when contacted by Bloomberg. Calls to Sinopharm Group went unanswered.

With the application, CNBG will likely become the first developer outside of Russia to see its shots made available for general public use, underscoring China's determination to be a major player in supplying inoculations to countries around the world.

Western drugmakers like Pfizer Inc. are only at the stage of seeking authorisation for emergency use of their shots, a status China granted to its developers months ago.

The race has taken on vital importance as countries look to more definitively re-open their economies and stem a pandemic that has sickened more than 59 million.

Working vaccines are seen as the best hope as a fresh wave of infections is forcing nations to reintroduce lockdowns and other restrictions.

A state-owned drugmaker that has a dominant share of China's vaccine market, CNBG in April was among the world's first to push experimental shots to the crucial final stage of human testing. The company's research institutes developed two shots using an inactivated version of the virus to stimulate immune response, an approach widely adopted by many of the existing vaccines used around the world.

Despite the fact that the vaccines haven't yet received regulatory approval for widespread use, they have already been given to hundreds of thousands of people in China under an emergency-use program. That has raised concern among scientists of potential risks in using shots whose safety has yet to be thoroughly studied.

CNBG has said that its phase III trials - involving more than 50,000 people in countries from Argentina to Egypt - have been progressing smoothly, and it has not received any reports of serious adverse events.

Safety has become a major concern as drugmakers compress the vaccine development process from years to a matter of months.

AstraZeneca Plc and Johnson & Johnson paused their trials after a participant developed an unexplained illness. Another Chinese frontrunner, Sinovac Biotech Ltd., also saw its trial briefly halted in Brazil after a participant died.

All three trials resumed after investigators found no evidence that the events were caused by the vaccines.

Pfizer said this month that the shot it co-developed with BioNTech has a protection rate of more than 90 per cent. Russia later declared that its Sputnik V vaccine has achieved a protection rate of 92 per cent. CNBG has not released any public data on the efficacy of its shots.

I am a bit concerned that they havn't released efficacy rates. I actually think its likely that the efficacy rate is too high (ie. 98%+) rather than being too low (since its an inactivated vaccine that allows the body to eat the whole virus), and might be at a loss of credibility. This is coming from the fact that brazil said it was the best of the vaccines they were testing, and they are testing all of them so far. China already hinted earlier it wasn't going to accept a vaccine with under 70% efficacy, and astra zeneca already established a lower bound of ~70% which should be easy for at least 1 of the 4 chinese vaccines to clear.
 

KYli

Captain
There is too much unknown at the moment to really pinpoint what is the best course of actions. I am thinking to take the vaccine somewhere from around late April to June. For Pfizer and Moderna vaccines, it would probably require a few months to know if there are serious side effects after more people got vaccinated.

It is a tough situation for senior citizens such as my parents since they are much more vulnerable and should take the vaccine sooner rather than later to avoid contracting the virus.

I am not too worry about efficacy rate at the moment but more worry about the side effects. Don't think we would have good and accurate picture of efficacy rate til months after the rollout of national vaccination.
 

KYli

Captain
Look like if you took a vaccine and later found out that particular vaccine has low efficacy rate, injecting yourself with another high efficacy rate vaccine would not necessary boost your immune system. So both side effects and efficacy rate need to be considered before taking any vaccine.
 

Intrepid

Captain
In the first quarter of 2021, when only a few vaccine doses are available, the experience in handling is lacking and the processes have to be established, young high-risk patients and medical staff will be vaccinated in Germany. In the second quarter also the members of other systemically relevant professions. The general population will be vaccinated in the second half of 2021. The vaccination campaign will not be completed until 2022, as long as the pandemic will remain an issue.
 

quantumlight

Junior Member
Registered Member
How do yall see the general covid situation playing out in the US for rest of this year and into jan/feb 2021? Is it really gonna be as bad as some say or was it hyped up for election and now going to be downplayed since Biden won? Seems like the death rate is very low now, perhaps covid has evolved to a mild flu in severity?
 

Top